HEADER HYDRALASE/INHIBITOR 21-FEB-19 6JIJ
TITLE THE CRYSTAL STRUCTURE OF MAIN PROTEASE FROM MOUSE HEPATITIS VIRUS A59
TITLE 2 IN COMPLEX WITH AN INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: REPLICATIVE POLYPROTEIN 1AB;
COMPND 3 CHAIN: B, C, A;
COMPND 4 ENGINEERED: YES;
COMPND 5 MOL_ID: 2;
COMPND 6 MOLECULE: 02J-ALA-VAL-LEU-PJE-010;
COMPND 7 CHAIN: D, E, F;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: MURINE CORONAVIRUS (STRAIN A59);
SOURCE 3 ORGANISM_COMMON: MHV-A59;
SOURCE 4 ORGANISM_TAXID: 11142;
SOURCE 5 STRAIN: A59;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 MOL_ID: 2;
SOURCE 9 SYNTHETIC: YES;
SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT;
SOURCE 11 ORGANISM_TAXID: 32630
KEYWDS MAIN PROTEASE, MOUSE HEPATITIS VIRUS A59, HYDRALASE-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR W.CUI,S.S.CUI
REVDAT 4 23-OCT-24 6JIJ 1 REMARK
REVDAT 3 15-NOV-23 6JIJ 1 LINK ATOM
REVDAT 2 19-FEB-20 6JIJ 1 REMARK SITE
REVDAT 1 24-APR-19 6JIJ 0
JRNL AUTH W.CUI,S.CUI,C.CHEN,X.CHEN,Z.WANG,H.YANG,L.ZHANG
JRNL TITL THE CRYSTAL STRUCTURE OF MAIN PROTEASE FROM MOUSE HEPATITIS
JRNL TITL 2 VIRUS A59 IN COMPLEX WITH AN INHIBITOR.
JRNL REF BIOCHEM. BIOPHYS. RES. V. 511 794 2019
JRNL REF 2 COMMUN.
JRNL REFN ESSN 1090-2104
JRNL PMID 30833083
JRNL DOI 10.1016/J.BBRC.2019.02.105
REMARK 2
REMARK 2 RESOLUTION. 2.65 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (1.14_3260: ???)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.96
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 3 NUMBER OF REFLECTIONS : 29710
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.229
REMARK 3 R VALUE (WORKING SET) : 0.226
REMARK 3 FREE R VALUE : 0.270
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060
REMARK 3 FREE R VALUE TEST SET COUNT : 1502
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 36.9647 - 5.8753 0.99 2645 158 0.1782 0.2045
REMARK 3 2 5.8753 - 4.6664 1.00 2589 145 0.1954 0.2445
REMARK 3 3 4.6664 - 4.0774 1.00 2568 131 0.1927 0.2636
REMARK 3 4 4.0774 - 3.7049 1.00 2585 150 0.2303 0.2692
REMARK 3 5 3.7049 - 3.4396 1.00 2586 116 0.2543 0.3002
REMARK 3 6 3.4396 - 3.2369 1.00 2555 145 0.2797 0.3222
REMARK 3 7 3.2369 - 3.0749 1.00 2569 131 0.2756 0.2901
REMARK 3 8 3.0749 - 2.9411 1.00 2576 137 0.2895 0.3062
REMARK 3 9 2.9411 - 2.8279 1.00 2536 140 0.2764 0.3615
REMARK 3 10 2.8279 - 2.7304 0.99 2564 126 0.2936 0.3456
REMARK 3 11 2.7304 - 2.6450 0.95 2435 123 0.3087 0.3862
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.250
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.004 7156
REMARK 3 ANGLE : 0.772 9736
REMARK 3 CHIRALITY : 0.050 1109
REMARK 3 PLANARITY : 0.004 1243
REMARK 3 DIHEDRAL : 13.557 4126
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6JIJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-19.
REMARK 100 THE DEPOSITION ID IS D_1300011177.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 02-SEP-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SSRF
REMARK 200 BEAMLINE : BL17B1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97854
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29741
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7
REMARK 200 DATA REDUNDANCY : 3.300
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 52.42
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM ACETATE TRIHYDRATE (PH 4.4
REMARK 280 -4.6), 8%-10%(W/V) POLYETHYLENE GLYCOL 4,000, MICROBATCH,
REMARK 280 TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 83.89350
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.01700
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 83.89350
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.01700
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, D, F
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, E
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 98.50594
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 95.46227
REMARK 400
REMARK 400 COMPOUND
REMARK 400
REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-
REMARK 400 4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)
REMARK 400 -L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,
REMARK 400 2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]
REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE
REMARK 400 CHAIN: D, E, F
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: NULL
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 VAL B 298
REMARK 465 LYS B 299
REMARK 465 LEU B 300
REMARK 465 GLN B 301
REMARK 465 LYS C 299
REMARK 465 LEU C 300
REMARK 465 GLN C 301
REMARK 465 VAL A 298
REMARK 465 LYS A 299
REMARK 465 LEU A 300
REMARK 465 GLN A 301
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 SG CYS C 143 C20 PJE E 5 1.76
REMARK 500 SG CYS B 143 C20 PJE D 5 1.77
REMARK 500 SG CYS A 143 C20 PJE F 5 1.77
REMARK 500 OG SER B 1 O PHE A 138 2.04
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 CD1 LEU B 244 C3 010 F 6 2555 1.50
REMARK 500 CD1 LEU B 244 C2 010 F 6 2555 1.76
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 VAL D 3 C LEU D 4 N 0.144
REMARK 500 VAL E 3 C LEU E 4 N 0.142
REMARK 500 VAL F 3 C LEU F 4 N 0.148
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 LEU B 244 CA - CB - CG ANGL. DEV. = 17.4 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP B 33 -121.17 54.98
REMARK 500 CYS B 44 -79.59 -101.13
REMARK 500 SER B 45 -31.42 77.82
REMARK 500 ASP B 46 34.86 -93.83
REMARK 500 MET B 47 -177.07 59.48
REMARK 500 THR B 48 -124.79 42.47
REMARK 500 GLN B 162 -36.41 -142.21
REMARK 500 GLN B 187 42.94 -83.27
REMARK 500 ARG B 213 -63.32 66.04
REMARK 500 ASN B 215 22.07 -142.77
REMARK 500 ALA B 296 -71.08 -129.47
REMARK 500 ASP C 33 -118.57 58.43
REMARK 500 MET C 47 157.04 74.57
REMARK 500 ASP C 49 77.40 -151.86
REMARK 500 ASP C 51 58.98 -101.02
REMARK 500 GLN C 162 -29.65 -142.29
REMARK 500 PRO C 182 46.50 -91.04
REMARK 500 GLN C 187 46.54 -85.62
REMARK 500 ASN C 212 31.14 -98.89
REMARK 500 ASP A 33 -120.54 57.66
REMARK 500 CYS A 44 -81.13 -91.14
REMARK 500 SER A 45 -3.94 63.94
REMARK 500 MET A 47 178.18 58.87
REMARK 500 THR A 48 -114.34 44.80
REMARK 500 ASP A 51 69.75 -114.78
REMARK 500 THR A 151 71.61 -105.81
REMARK 500 GLN A 162 -30.19 -144.20
REMARK 500 SER A 269 31.40 -93.55
REMARK 500 ALA A 296 -57.38 -128.74
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A 505 DISTANCE = 5.94 ANGSTROMS
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: CHAIN
REMARK 800 SITE_DESCRIPTION: binding site for "N-[(5-METHYLISOXAZOL-3
REMARK 800 -YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{
REMARK 800 [(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: NULL
REMARK 800 SITE_DESCRIPTION: NULL
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: NULL
REMARK 800 SITE_DESCRIPTION: NULL
DBREF 6JIJ B 1 301 UNP Q66WN6 Q66WN6_CVMA5 3334 3636
DBREF 6JIJ C 1 301 UNP Q66WN6 Q66WN6_CVMA5 3334 3636
DBREF 6JIJ A 1 301 UNP Q66WN6 Q66WN6_CVMA5 3334 3636
DBREF 6JIJ D 1 6 PDB 6JIJ 6JIJ 1 6
DBREF 6JIJ E 1 6 PDB 6JIJ 6JIJ 1 6
DBREF 6JIJ F 1 6 PDB 6JIJ 6JIJ 1 6
SEQADV 6JIJ B UNP Q66WN6 SER 3379 DELETION
SEQADV 6JIJ B UNP Q66WN6 ALA 3380 DELETION
SEQADV 6JIJ PHE B 282 UNP Q66WN6 LEU 3617 CONFLICT
SEQADV 6JIJ C UNP Q66WN6 SER 3379 DELETION
SEQADV 6JIJ C UNP Q66WN6 ALA 3380 DELETION
SEQADV 6JIJ PHE C 282 UNP Q66WN6 LEU 3617 CONFLICT
SEQADV 6JIJ A UNP Q66WN6 SER 3379 DELETION
SEQADV 6JIJ A UNP Q66WN6 ALA 3380 DELETION
SEQADV 6JIJ PHE A 282 UNP Q66WN6 LEU 3617 CONFLICT
SEQRES 1 B 301 SER GLY ILE VAL LYS MET VAL SER PRO THR SER LYS VAL
SEQRES 2 B 301 GLU PRO CYS ILE VAL SER VAL THR TYR GLY ASN MET THR
SEQRES 3 B 301 LEU ASN GLY LEU TRP LEU ASP ASP LYS VAL TYR CYS PRO
SEQRES 4 B 301 ARG HIS VAL ILE CYS SER ASP MET THR ASP PRO ASP TYR
SEQRES 5 B 301 PRO ASN LEU LEU CYS ARG VAL THR SER SER ASP PHE CYS
SEQRES 6 B 301 VAL MET SER GLY ARG MET SER LEU THR VAL MET SER TYR
SEQRES 7 B 301 GLN MET GLN GLY CYS GLN LEU VAL LEU THR VAL THR LEU
SEQRES 8 B 301 GLN ASN PRO ASN THR PRO LYS TYR SER PHE GLY VAL VAL
SEQRES 9 B 301 LYS PRO GLY GLU THR PHE THR VAL LEU ALA ALA TYR ASN
SEQRES 10 B 301 GLY ARG PRO GLN GLY ALA PHE HIS VAL THR LEU ARG SER
SEQRES 11 B 301 SER HIS THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS
SEQRES 12 B 301 GLY SER VAL GLY TYR VAL LEU THR GLY ASP SER VAL ARG
SEQRES 13 B 301 PHE VAL TYR MET HIS GLN LEU GLU LEU SER THR GLY CYS
SEQRES 14 B 301 HIS THR GLY THR ASP PHE SER GLY ASN PHE TYR GLY PRO
SEQRES 15 B 301 TYR ARG ASP ALA GLN VAL VAL GLN LEU PRO VAL GLN ASP
SEQRES 16 B 301 TYR THR GLN THR VAL ASN VAL VAL ALA TRP LEU TYR ALA
SEQRES 17 B 301 ALA ILE PHE ASN ARG CYS ASN TRP PHE VAL GLN SER ASP
SEQRES 18 B 301 SER CYS SER LEU GLU GLU PHE ASN VAL TRP ALA MET THR
SEQRES 19 B 301 ASN GLY PHE SER SER ILE LYS ALA ASP LEU VAL LEU ASP
SEQRES 20 B 301 ALA LEU ALA SER MET THR GLY VAL THR VAL GLU GLN VAL
SEQRES 21 B 301 LEU ALA ALA ILE LYS ARG LEU HIS SER GLY PHE GLN GLY
SEQRES 22 B 301 LYS GLN ILE LEU GLY SER CYS VAL PHE GLU ASP GLU LEU
SEQRES 23 B 301 THR PRO SER ASP VAL TYR GLN GLN LEU ALA GLY VAL LYS
SEQRES 24 B 301 LEU GLN
SEQRES 1 C 301 SER GLY ILE VAL LYS MET VAL SER PRO THR SER LYS VAL
SEQRES 2 C 301 GLU PRO CYS ILE VAL SER VAL THR TYR GLY ASN MET THR
SEQRES 3 C 301 LEU ASN GLY LEU TRP LEU ASP ASP LYS VAL TYR CYS PRO
SEQRES 4 C 301 ARG HIS VAL ILE CYS SER ASP MET THR ASP PRO ASP TYR
SEQRES 5 C 301 PRO ASN LEU LEU CYS ARG VAL THR SER SER ASP PHE CYS
SEQRES 6 C 301 VAL MET SER GLY ARG MET SER LEU THR VAL MET SER TYR
SEQRES 7 C 301 GLN MET GLN GLY CYS GLN LEU VAL LEU THR VAL THR LEU
SEQRES 8 C 301 GLN ASN PRO ASN THR PRO LYS TYR SER PHE GLY VAL VAL
SEQRES 9 C 301 LYS PRO GLY GLU THR PHE THR VAL LEU ALA ALA TYR ASN
SEQRES 10 C 301 GLY ARG PRO GLN GLY ALA PHE HIS VAL THR LEU ARG SER
SEQRES 11 C 301 SER HIS THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS
SEQRES 12 C 301 GLY SER VAL GLY TYR VAL LEU THR GLY ASP SER VAL ARG
SEQRES 13 C 301 PHE VAL TYR MET HIS GLN LEU GLU LEU SER THR GLY CYS
SEQRES 14 C 301 HIS THR GLY THR ASP PHE SER GLY ASN PHE TYR GLY PRO
SEQRES 15 C 301 TYR ARG ASP ALA GLN VAL VAL GLN LEU PRO VAL GLN ASP
SEQRES 16 C 301 TYR THR GLN THR VAL ASN VAL VAL ALA TRP LEU TYR ALA
SEQRES 17 C 301 ALA ILE PHE ASN ARG CYS ASN TRP PHE VAL GLN SER ASP
SEQRES 18 C 301 SER CYS SER LEU GLU GLU PHE ASN VAL TRP ALA MET THR
SEQRES 19 C 301 ASN GLY PHE SER SER ILE LYS ALA ASP LEU VAL LEU ASP
SEQRES 20 C 301 ALA LEU ALA SER MET THR GLY VAL THR VAL GLU GLN VAL
SEQRES 21 C 301 LEU ALA ALA ILE LYS ARG LEU HIS SER GLY PHE GLN GLY
SEQRES 22 C 301 LYS GLN ILE LEU GLY SER CYS VAL PHE GLU ASP GLU LEU
SEQRES 23 C 301 THR PRO SER ASP VAL TYR GLN GLN LEU ALA GLY VAL LYS
SEQRES 24 C 301 LEU GLN
SEQRES 1 A 301 SER GLY ILE VAL LYS MET VAL SER PRO THR SER LYS VAL
SEQRES 2 A 301 GLU PRO CYS ILE VAL SER VAL THR TYR GLY ASN MET THR
SEQRES 3 A 301 LEU ASN GLY LEU TRP LEU ASP ASP LYS VAL TYR CYS PRO
SEQRES 4 A 301 ARG HIS VAL ILE CYS SER ASP MET THR ASP PRO ASP TYR
SEQRES 5 A 301 PRO ASN LEU LEU CYS ARG VAL THR SER SER ASP PHE CYS
SEQRES 6 A 301 VAL MET SER GLY ARG MET SER LEU THR VAL MET SER TYR
SEQRES 7 A 301 GLN MET GLN GLY CYS GLN LEU VAL LEU THR VAL THR LEU
SEQRES 8 A 301 GLN ASN PRO ASN THR PRO LYS TYR SER PHE GLY VAL VAL
SEQRES 9 A 301 LYS PRO GLY GLU THR PHE THR VAL LEU ALA ALA TYR ASN
SEQRES 10 A 301 GLY ARG PRO GLN GLY ALA PHE HIS VAL THR LEU ARG SER
SEQRES 11 A 301 SER HIS THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS
SEQRES 12 A 301 GLY SER VAL GLY TYR VAL LEU THR GLY ASP SER VAL ARG
SEQRES 13 A 301 PHE VAL TYR MET HIS GLN LEU GLU LEU SER THR GLY CYS
SEQRES 14 A 301 HIS THR GLY THR ASP PHE SER GLY ASN PHE TYR GLY PRO
SEQRES 15 A 301 TYR ARG ASP ALA GLN VAL VAL GLN LEU PRO VAL GLN ASP
SEQRES 16 A 301 TYR THR GLN THR VAL ASN VAL VAL ALA TRP LEU TYR ALA
SEQRES 17 A 301 ALA ILE PHE ASN ARG CYS ASN TRP PHE VAL GLN SER ASP
SEQRES 18 A 301 SER CYS SER LEU GLU GLU PHE ASN VAL TRP ALA MET THR
SEQRES 19 A 301 ASN GLY PHE SER SER ILE LYS ALA ASP LEU VAL LEU ASP
SEQRES 20 A 301 ALA LEU ALA SER MET THR GLY VAL THR VAL GLU GLN VAL
SEQRES 21 A 301 LEU ALA ALA ILE LYS ARG LEU HIS SER GLY PHE GLN GLY
SEQRES 22 A 301 LYS GLN ILE LEU GLY SER CYS VAL PHE GLU ASP GLU LEU
SEQRES 23 A 301 THR PRO SER ASP VAL TYR GLN GLN LEU ALA GLY VAL LYS
SEQRES 24 A 301 LEU GLN
SEQRES 1 D 6 02J ALA VAL LEU PJE 010
SEQRES 1 E 6 02J ALA VAL LEU PJE 010
SEQRES 1 F 6 02J ALA VAL LEU PJE 010
HET 02J D 1 8
HET PJE D 5 13
HET 010 D 6 8
HET 02J E 1 8
HET PJE E 5 13
HET 010 E 6 8
HET 02J F 1 8
HET PJE F 5 13
HET 010 F 6 8
HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID
HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3-
HETNAM 2 PJE YL]PENT-2-ENOIC ACID
HETNAM 010 PHENYLMETHANOL
FORMUL 4 02J 3(C5 H5 N O3)
FORMUL 4 PJE 3(C9 H14 N2 O3)
FORMUL 4 010 3(C7 H8 O)
FORMUL 7 HOH *11(H2 O)
HELIX 1 AA1 VAL B 13 PRO B 15 5 3
HELIX 2 AA2 HIS B 41 CYS B 44 5 4
HELIX 3 AA3 ASP B 51 VAL B 59 1 9
HELIX 4 AA4 THR B 60 PHE B 64 5 5
HELIX 5 AA5 GLN B 198 ASN B 212 1 15
HELIX 6 AA6 SER B 224 MET B 233 1 10
HELIX 7 AA7 ASP B 243 GLY B 254 1 12
HELIX 8 AA8 THR B 256 HIS B 268 1 13
HELIX 9 AA9 THR B 287 ALA B 296 1 10
HELIX 10 AB1 VAL C 13 PRO C 15 5 3
HELIX 11 AB2 HIS C 41 CYS C 44 5 4
HELIX 12 AB3 ASP C 51 LEU C 56 1 6
HELIX 13 AB4 CYS C 57 VAL C 59 5 3
HELIX 14 AB5 THR C 60 SER C 62 5 3
HELIX 15 AB6 GLN C 198 ASN C 212 1 15
HELIX 16 AB7 SER C 224 MET C 233 1 10
HELIX 17 AB8 ASP C 243 GLY C 254 1 12
HELIX 18 AB9 THR C 256 LEU C 267 1 12
HELIX 19 AC1 THR C 287 ALA C 296 1 10
HELIX 20 AC2 VAL A 13 PRO A 15 5 3
HELIX 21 AC3 HIS A 41 CYS A 44 5 4
HELIX 22 AC4 ASP A 51 VAL A 59 1 9
HELIX 23 AC5 THR A 60 SER A 62 5 3
HELIX 24 AC6 GLN A 198 ASN A 212 1 15
HELIX 25 AC7 SER A 224 MET A 233 1 10
HELIX 26 AC8 ASP A 243 GLY A 254 1 12
HELIX 27 AC9 THR A 256 HIS A 268 1 13
HELIX 28 AD1 THR A 287 GLN A 294 1 8
SHEET 1 AA1 7 MET B 71 LEU B 73 0
SHEET 2 AA1 7 CYS B 65 SER B 68 -1 N VAL B 66 O LEU B 73
SHEET 3 AA1 7 ILE B 17 TYR B 22 -1 N SER B 19 O MET B 67
SHEET 4 AA1 7 MET B 25 LEU B 32 -1 O GLY B 29 N VAL B 18
SHEET 5 AA1 7 LYS B 35 PRO B 39 -1 O LYS B 35 N LEU B 32
SHEET 6 AA1 7 GLN B 84 VAL B 89 -1 O LEU B 85 N CYS B 38
SHEET 7 AA1 7 VAL B 75 GLN B 81 -1 N MET B 76 O THR B 88
SHEET 1 AA2 5 TYR B 99 PHE B 101 0
SHEET 2 AA2 5 SER B 154 SER B 166 1 O VAL B 155 N SER B 100
SHEET 3 AA2 5 VAL B 146 THR B 151 -1 N THR B 151 O SER B 154
SHEET 4 AA2 5 THR B 109 TYR B 116 -1 N LEU B 113 O VAL B 146
SHEET 5 AA2 5 ARG B 119 THR B 127 -1 O GLN B 121 N ALA B 114
SHEET 1 AA3 3 TYR B 99 PHE B 101 0
SHEET 2 AA3 3 SER B 154 SER B 166 1 O VAL B 155 N SER B 100
SHEET 3 AA3 3 CYS B 169 THR B 173 -1 O THR B 171 N LEU B 163
SHEET 1 AA4 7 MET C 71 LEU C 73 0
SHEET 2 AA4 7 PHE C 64 SER C 68 -1 N SER C 68 O MET C 71
SHEET 3 AA4 7 ILE C 17 TYR C 22 -1 N THR C 21 O CYS C 65
SHEET 4 AA4 7 MET C 25 LEU C 32 -1 O GLY C 29 N VAL C 18
SHEET 5 AA4 7 LYS C 35 PRO C 39 -1 O LYS C 35 N LEU C 32
SHEET 6 AA4 7 GLN C 84 VAL C 89 -1 O LEU C 85 N CYS C 38
SHEET 7 AA4 7 VAL C 75 SER C 77 -1 N SER C 77 O THR C 88
SHEET 1 AA5 7 MET C 71 LEU C 73 0
SHEET 2 AA5 7 PHE C 64 SER C 68 -1 N SER C 68 O MET C 71
SHEET 3 AA5 7 ILE C 17 TYR C 22 -1 N THR C 21 O CYS C 65
SHEET 4 AA5 7 MET C 25 LEU C 32 -1 O GLY C 29 N VAL C 18
SHEET 5 AA5 7 LYS C 35 PRO C 39 -1 O LYS C 35 N LEU C 32
SHEET 6 AA5 7 GLN C 84 VAL C 89 -1 O LEU C 85 N CYS C 38
SHEET 7 AA5 7 MET C 80 GLN C 81 -1 N GLN C 81 O GLN C 84
SHEET 1 AA6 5 TYR C 99 PHE C 101 0
SHEET 2 AA6 5 VAL C 155 SER C 166 1 O VAL C 155 N SER C 100
SHEET 3 AA6 5 VAL C 146 LEU C 150 -1 N VAL C 149 O ARG C 156
SHEET 4 AA6 5 THR C 109 TYR C 116 -1 N THR C 111 O TYR C 148
SHEET 5 AA6 5 ARG C 119 THR C 127 -1 O GLN C 121 N ALA C 114
SHEET 1 AA7 3 TYR C 99 PHE C 101 0
SHEET 2 AA7 3 VAL C 155 SER C 166 1 O VAL C 155 N SER C 100
SHEET 3 AA7 3 CYS C 169 THR C 173 -1 O THR C 173 N MET C 160
SHEET 1 AA8 7 MET A 71 LEU A 73 0
SHEET 2 AA8 7 PHE A 64 SER A 68 -1 N VAL A 66 O LEU A 73
SHEET 3 AA8 7 ILE A 17 TYR A 22 -1 N THR A 21 O CYS A 65
SHEET 4 AA8 7 MET A 25 LEU A 32 -1 O GLY A 29 N VAL A 18
SHEET 5 AA8 7 LYS A 35 PRO A 39 -1 O LYS A 35 N LEU A 32
SHEET 6 AA8 7 GLN A 84 THR A 88 -1 O LEU A 85 N CYS A 38
SHEET 7 AA8 7 MET A 80 GLN A 81 -1 N GLN A 81 O GLN A 84
SHEET 1 AA9 5 TYR A 99 PHE A 101 0
SHEET 2 AA9 5 SER A 154 SER A 166 1 O VAL A 155 N SER A 100
SHEET 3 AA9 5 VAL A 146 THR A 151 -1 N GLY A 147 O VAL A 158
SHEET 4 AA9 5 THR A 109 TYR A 116 -1 N THR A 111 O TYR A 148
SHEET 5 AA9 5 ARG A 119 THR A 127 -1 O GLN A 121 N ALA A 114
SHEET 1 AB1 3 TYR A 99 PHE A 101 0
SHEET 2 AB1 3 SER A 154 SER A 166 1 O VAL A 155 N SER A 100
SHEET 3 AB1 3 CYS A 169 THR A 173 -1 O THR A 173 N MET A 160
LINK C 02J D 1 N ALA D 2 1555 1555 1.45
LINK C LEU D 4 N PJE D 5 1555 1555 1.46
LINK C PJE D 5 O 010 D 6 1555 1555 1.43
LINK C 02J E 1 N ALA E 2 1555 1555 1.45
LINK C LEU E 4 N PJE E 5 1555 1555 1.46
LINK C PJE E 5 O 010 E 6 1555 1555 1.44
LINK C 02J F 1 N ALA F 2 1555 1555 1.45
LINK C LEU F 4 N PJE F 5 1555 1555 1.46
LINK C PJE F 5 O 010 F 6 1555 1555 1.42
SITE 1 AC1 16 MET B 25 HIS B 41 PHE B 138 LEU B 139
SITE 2 AC1 16 GLY B 141 SER B 142 CYS B 143 HIS B 161
SITE 3 AC1 16 GLN B 162 LEU B 163 GLU B 164 HIS B 170
SITE 4 AC1 16 GLN B 187 VAL B 188 VAL B 189 010 E 6
SITE 1 AC2 20 ASP B 46 MET B 47 MET C 25 HIS C 41
SITE 2 AC2 20 TYR C 52 PHE C 138 LEU C 139 CYS C 140
SITE 3 AC2 20 GLY C 141 CYS C 143 HIS C 161 GLN C 162
SITE 4 AC2 20 LEU C 163 GLU C 164 HIS C 170 ASP C 185
SITE 5 AC2 20 GLN C 187 VAL C 188 VAL C 189 02J D 1
SITE 1 AC3 14 MET A 25 HIS A 41 PHE A 138 GLY A 141
SITE 2 AC3 14 CYS A 143 HIS A 161 GLN A 162 LEU A 163
SITE 3 AC3 14 GLU A 164 HIS A 170 GLN A 187 VAL A 188
SITE 4 AC3 14 VAL A 189 LEU B 244
CRYST1 167.787 64.034 117.953 90.00 125.97 90.00 C 1 2 1 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.005960 0.000000 0.004326 0.00000
SCALE2 0.000000 0.015617 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010476 0.00000